https://www.clinicaltrialsarena.com/news/anaptys-reports-topline-positive-data-from-phase-iii-imsidolimab-trial/
Anaptys reports topline positive data from Phase III imsidolimab trial - Clinical Trials Arena
Oct 10, 2023 - The treatment caused rapid clearance of symptoms in patients with psoriasis, but Anaptys intends to out-licence the drug.